Treatment of adult T cell leukemia with mega-dose cyclophosphamide and total body irradiation followed by allogeneic bone marrow transplantation.
A 43-year-old patient with adult T cell leukemia (ATL) was treated with mega-dose cyclophosphamide and total body irradiation (TBI) followed by bone marrow transplantation (BMT) from his HLA-identical sibling who was not a carrier of ATL virus. After BMT, ATL cells rapidly decreased and disappeared, and the engraftment of marrow was confirmed on day 20. The patient showed normal hematologic recovery. However, he died on day 205 with interstitial pneumonitis caused by cytomegalovirus infection. Neither autopsy findings nor serologic and cytologic examinations showed any evidence of ATL relapse after BMT. This pilot study suggests that mega-dose chemotherapy and TBI followed by allogeneic BMT should be considered for such treatment of ATL.
Sobue
R
R
Division of Hematology, Japanese Red Cross Nagoya First Hospital, Japan.
Yamauchim
T
T
Miyamura
K
K
Sao
H
H
Tahara
T
T
Yoshikawa
H
H
Yoshikawa
S
S
Morishima
Y
Y
Kodera
Y
Y
D000328:Adult; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage*; D006410:Hematopoiesis; D006801:Humans; D015458:Leukemia, T-Cell / Q000628:therapy*; D008297:Male; D011658:Pulmonary Fibrosis / Q000209:etiology; D014916:Whole-Body Irradiation
D000945:Antigens, Differentiation, T-Lymphocyte; D003520:Cyclophosphamide